ARTICLE | Company News
Novartis, Mereo BioPharma deal
August 3, 2015 7:00 AM UTC
Start-up Mereo acquired three Phase II compounds from Novartis in exchange for an undisclosed equity stake. Novartis is eligible for milestone payments and royalties. BPS-804 is a human mAb for the O...